Neulasta 6 mg/.6mL
pegfilgrastim · INJECTION · Amgen, Inc
No Recall History
Plain English
Neulasta is a injection containing pegfilgrastim at 6 mg/.6mL, taken subcutaneous. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- Neulasta
- Generic Name
- pegfilgrastim
- NDC Code (Product)
55513-190- Manufacturer
- Amgen, Inc
- Strength
- 6 mg/.6mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125031
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 04/01/2002
Recall History
No Recall HistoryFrequently Asked Questions
What is Neulasta used for?
Neulasta contains pegfilgrastim. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is Neulasta a controlled substance?
Neulasta is not classified as a controlled substance by the DEA.
What is the generic name for Neulasta?
The generic name for Neulasta is pegfilgrastim. There are 10 other brand versions of pegfilgrastim.
What is the NDC code for Neulasta 6 mg/.6mL?
The NDC (National Drug Code) for Neulasta 6 mg/.6mL is 55513-190, listed by Amgen, Inc.